{{Rsnum
|rsid=3785143
|Gene=SLC6A2
|Chromosome=16
|position=55661194
|Orientation=plus
|GMAF=0.1038
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC6A2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 82.3 | 17.7 | 0.0
| HCB | 74.3 | 19.1 | 6.6
| JPT | 66.4 | 31.0 | 2.7
| YRI | 98.6 | 1.4 | 0.0
| ASW | 91.2 | 8.8 | 0.0
| CHB | 74.3 | 19.1 | 6.6
| CHD | 70.6 | 25.7 | 3.7
| GIH | 71.3 | 27.7 | 1.0
| LWK | 96.4 | 3.6 | 0.0
| MEX | 70.7 | 29.3 | 0.0
| MKK | 91.7 | 8.3 | 0.0
| TSI | 85.3 | 13.7 | 1.0
| HapMapRevision=28
}}T allele may be associated with [[Attention deficit hyperactivity disorder]]. {{PMID|18937296|OA=1
}} {{PMID|17876324}}

{{PMID Auto
|PMID=22297068
|Title=Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype.
|OA=1
}}

{{PMID Auto
|PMID=18937309
|Title=Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.
|OA=1
}}

{{PMID Auto
|PMID=23266789
|Title=Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children.
}}

{{PMID Auto
|PMID=25229170
|Title=Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}